| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |